Epstein Secrets

l-media platforms and additional forms of open-source data. Sources for Bulletin Intelligence audience-size estimates include Scarborough, GfK. MRI, comScore, Nielsen, and the Audit Bureau of Circulation. Data from and access to third party social media platforms, including but not limited to Facebook, T

escent Plasma. In an op-ed for the New York Times <https://www.nytimes.corn/2020/09/02/opinion/coronavirus-convalescent-plasma.html> (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate eviden

al-media platforms and additional forms of open-source data. Sources for Bulletin Intelligence audience-size estimates include Scarborough, Gil MRI, comScore, Nielsen, and the Audit Bureau of Circulation. Data from and access to third party social media platforms, including but not limited to Facebook, T

initive answer." Lamas: Insufficient Clinical Data For Efficacy Or Safety Of Convalescent Plasma. In an op-ed for the New York Times (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate evide

l-media platforms and additional forms of open-source data. Sources for Bulletin Intelligence audience-size estimates include Scarborough, Gfl< MRI, comScore, Nielsen, and the Audit Bureau of Circulation. Data from and access to third party social media platforms, including but not limited to Facebook, T

initive answer." Lamas: Insufficient Clinical Data For Efficacy Or Safety Of Convalescent Plasma. In an op-ed for the New York Times (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate evide